Vaccines tested on animals for the treatment of the global pandemic corona virus have yielded encouraging results, raising hopes of an early availability of the corona vaccine.
According to a report by the British Broadcasting Corporation, the Code 19 vaccine was tested on six monkeys of a species of monkeys found mostly in Asia and the results showed that the vaccine protected them from the corona virus.
According to the report, the monkeys were first infected with the corona virus and then vaccinated. The six monkeys vaccinated had fewer viruses in their lungs and respiratory tract.
The experiment was conducted in the United States with the participation of scientists from the National Institutes of Health in the United States and the University of Oxford in the United Kingdom.
The vaccine also helped prevent monkeys from getting pneumonia. Keep in mind that the Rhesus monkey of Asian descent has the same immune system as the human immune system, so it was selected for the experiment.
Fortunately, the vaccine did not cause any other disease in monkeys as the immune system was over-activated, as was feared with this vaccine. Due to which the preparation of the vaccine had to be stopped there.
Other scientists have not yet commented on the experiment and it has not been officially published, but Stephen Evans, a professor at the London School of Hygiene and Tropical Medicine, described it as “very encouraging”.
The vaccine is also being tested on humans in England, and currently the results from monkeys do not indicate that the vaccine will have the same effect on humans.
The vaccine is being tested on about 1,000 volunteers under the auspices of the University of Oxford in the United Kingdom, while more than 100 vaccines for the corona virus are being tested worldwide.